Voruciclib

DB15157InvestigationalSmall molecule

Voruciclib is under investigation in clinical trial NCT03547115 (A Phase 1 Study of Voruciclib in Subjects With B-Cell Malignancies or AML).

Chemical structure of Voruciclib
Mechanism
Curator reviewed
Formula / weight
C22H19ClF3NO5 · 469.84 g/mol (avg)

Resolves to

Compound
UNIIW66XP666AMCAS1000023-04-0ChEMBLCHEMBL3905910
Structure
InChIKeyMRPGRAKIAJJGMM-OCCSQVGLSA-NSMILESCN1CC[C@H]([C@@H]1CO)C1=C(O)C=C(O)C2=C1OC(=CC2=O)C1=CC=C(C=C1Cl)C(F)(F)F
Targets
P11802CDK4

What you can answer from here — as of June 15, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
39Drug interactionsStructured to mechanism, not free text
Sign in
1Clinical trialPhase, status and sponsor resolved per trial
Sign in
2+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Voruciclib, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In